Abstract:Background: Alternative splicing diversifies calcium channel structure to change channel properties. Results: Extensive C-terminal alternative splicing generates channels differing in activation potential and voltage- and calcium-dependent inactivation properties. Conclusion: Diversification of channel function through altered structure is fine-tuned by alternative splicing. Significance: CaV1.4 C-terminal splice variations recapitulate some aspects of native photoreceptor calcium currents. The CaV1.4 voltage-gated calcium channel is predominantly expressed in the retina, and mutations to this channel have been associated with human congenital stationary night blindness type-2. The L-type CaV1.4 channel displays distinct properties such as absence of calcium-dependent inactivation (CDI) and slow voltage-dependent inactivation (VDI) due to the presence of an autoinhibitory domain (inhibitor of CDI) in the distal C terminus. We hypothesized that native CaV1.4 is subjected to extensive alternative splicing, much like the other voltage-gated calcium channels, and employed the transcript scanning method to identify alternatively spliced exons within the CaV1.4 transcripts isolated from the human retina. In total, we identified 19 alternative splice variations, of which 16 variations have not been previously reported. Characterization of the C terminus alternatively spliced exons using whole-cell patch clamp electrophysiology revealed a splice variant that exhibits robust CDI. This splice variant arose from the splicing of a novel alternate exon (43*) that can be found in 13.6% of the full-length transcripts screened. Inclusion of exon 43* inserts a stop codon that truncates half the C terminus. The CaV1.4 43* channel exhibited robust CDI, a larger current density, a hyperpolarized shift in activation potential by ∼10 mV, and a slower VDI. Through deletional experiments, we showed that the inhibitor of CDI was responsible for modulating channel activation and VDI, in addition to CDI. Calcium currents in the photoreceptors were observed to exhibit CDI and are more negatively activated as compared with currents elicited from heterologously expressed full-length CaV1.4. Naturally occurring alternative splice variants may in part contribute to the properties of the native CaV1.4 channels.

Alternative Splicing Modulates Diltiazem Sensitivity of Cardiac and Vascular Smooth Muscle Cav1.2 Calcium Channels

Smooth Muscle Tissues Express a Major Dominant Negative Splice Variant of the Type 3 Ca2+ Release Channel (ryanodine Receptor).

C-terminal alternative splicing of CaV1.3 channels distinctively modulates their dihydropyridine sensitivity.

A Smooth Muscle Cav1.2 Calcium Channel Splice Variant Underlies Hyperpolarized Window Current and Enhanced State-Dependent Inhibition by Nifedipine.

Differential splicing patterns of L-type calcium channel Cav1.2 subunit in hearts of Spontaneously Hypertensive Rats and Wistar Kyoto Rats.

Smooth Muscle-Selective Alternatively Spliced Exon Generates Functional Variation In Ca(V)1.2 Calcium Channels

Alternative Splicing of Cav1.2 Channel Exons in Smooth Muscle Cells of Resistance-Size Arteries Generates Currents with Unique Electrophysiological Properties.

Effects of Diltiazem on Platelet Activation and Cytosolic Calcium During Percutaneous Transluminal Coronary Angioplasty.

Selectivity of calcium antagonistic action in vascular smooth muscle

CaV1.2 Channel N-terminal Splice Variants Modulate Functional Surface Expression in Resistance Size Artery Smooth Muscle Cells

Alternative Splicing at N Terminus and Domain I Modulates Ca(v)1.2 Inactivation and Surface Expression

Alternative Splicing at C Terminus of CaV1.4 Calcium Channel Modulates Calcium-dependent Inactivation, Activation Potential, and Current Density

Aberrant Splicing Promotes Proteasomal Degradation Of L-Type Ca(V)1.2 Calcium Channels By Competitive Binding For Ca-V Beta Subunits In Cardiac Hypertrophy

Molecular alteration of Ca v 1.2 calcium channel in chronic myocardial infarction

Functional Characterization of Alternative Splicing in the C Terminus of L-type CaV1.3 Channels.

Aberrant Splicing Promotes Proteasomal Degradation of L-type Ca V 1.2 Calcium Channels by Competitive Binding for Ca V β Subunits in Cardiac Hypertrophy

Molecular determinants of drug binding and action on L-type calcium channels

Transcript Scanning Reveals Novel and Extensive Splice Variations in Human L-type Voltage-gated Calcium Channel, Cav1.2 Α1 Subunit

Advanced Measurement and Quantitative Appraise of Anisodamine on Calcium Triggered in Cardiac Myocyte

Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs

Differential Modulations of KCNQ1 by Auxiliary Proteins KCNE1 and KCNE2